Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial

BACKGROUND: Cutaneous microcystic lymphatic malformations (CMLMs) are rare conditions in children and adults. They present as clusters of vesicles full of lymph and blood to various extents, inducing maceration, esthetic impairment, pain, and impaired quality of life. The treatment is challenging. S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Leducq, Sophie, Caille, Agnès, Barbarot, Sébastien, Bénéton, Nathalie, Bessis, Didier, Boccara, Olivia, Bursztejn, Anne-Claire, Chiaverini, Christine, Dompmartin, Anne, Droitcourt, Catherine, Gissot, Valérie, Goga, Dominique, Guibaud, Laurent, Herbreteau, Denis, Le Touze, Anne, Léauté-Labrèze, Christine, Lorette, Gérard, Mallet, Stéphanie, Martin, Ludovic, Mazereeuw-Hautier, Juliette, Phan, Alice, Plantin, Patrice, Quéré, Isabelle, Vabres, Pierre, Bourgoin, Hélène, Giraudeau, Bruno, Maruani, Annabel
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6918625/
https://ncbi.nlm.nih.gov/pubmed/31847908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3767-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars